Bioavailability of Two Single-Dose Oral Formulations of Omeprazole 20 mg: An Open-Label, Randomized Sequence, Two-Period Crossover Comparison in Healthy Mexican Adult Volunteers

Clinical Therapeutics

Volumn 30, Issue 4, 2008, Pages 693-699

  Poo, Jorge Luis ^a   Galán, Juan Francisco ^a   Rosete, Alejandra ^a   de Lago, Alberto ^b   Oliva, Iván ^b   González de la Parra, Mario ^b   Jiménez, Patricia ^b   Burke Fraga, Victoria ^b   Namur, Salvador ^b  

^a LIVER RESEARCH UNIT   (Mexico)

^b Fundacion Liomont AC   (Mexico)

Author keywords

bioavailability; bioequivalence; high performance liquid chromatography; omeprazole; pharmacokinetic

Indexed keywords

INHIBITRON; OMEPRAZOLE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG MARKETING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LABORATORY TEST; MALE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; VITAL SIGN;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MEXICO; OMEPRAZOLE; REFERENCE VALUES;

EID: 43549108303     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.04.004     Document Type: Article

References (17)